May 30 2015
Mazor Robotics, a developer of innovative guidance systems and complementary products, announced that Dr. Isador Lieberman, a leading orthopaedic spine surgeon from Dallas, Texas, performed a live surgical procedure using the Company’s Renaissance® system at the Joint Congress of the Chinese Association of Orthopaedic Surgeons and North American Spine Society. The procedure was performed in front of 1,000 attending surgeons.
During his two week trip to China, Dr. Lieberman visited several hospitals across the country and presented the clinical benefits of robotic spine surgery. Since 2010, Dr. Lieberman has been the head of the Scoliosis and Spine Tumor Unit at Texas Back Institute in Plano, Texas. He was previously head of the Cleveland Clinic's Spine Program in Florida.
“The spine market is one of the fastest growing segments in the Chinese surgery market. The size of the market and the continued adoption of new technologies make it an ideal opportunity for Mazor Robotics,” said Ori Hadomi, Mazor's Chief Executive Officer. “Our presence at the conference and the live demonstration by Dr. Lieberman, which was observed by 1,000 surgeons, allowed us to increase the awareness of Renaissance while reinforcing the applicability and relevance to the Chinese market."
Last September, the China Food and Drug Administration (CFDA) approved the Company’s Renaissance system for use in the country, allowing Mazor to begin marketing the system in China. Additionally, Mazor signed a distribution partnership with Beijing-based Cicel Science & Technology Co., LTD ("Cicel"), a leading medical equipment distributor with a deep knowledge of the market. Cicel has purchased two Renaissance systems since the CFDA approval.
Renaissance improves the execution and results in a wide variety of spine procedures, including minimally-invasive approaches, for both degenerative spine disease and spinal deformity. To date, Renaissance has been used in over 1,000 spinal deformity corrections and thousands of minimally invasive procedures.